Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study
Jujić A, Atabaki-Pasdar N, Nilsson PM, et al.
Diabetologia. 2020;63:1043-54
Leggi
Diabetes is a risk factor for the progression and prognosis of COVID-19
Guo W, Li M, Dong Y, et al.
Diabetes Metab Res Rev. Pub. online 31 March 2020
Leggi
Association between preoperative metformin exposure and postoperative outcomes in adults with type 2 diabetes
Reitz KM, Marroquin OC, Zenati MS, et al.
JAMA Surg. Pub. online 8 April 2020
Leggi
Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes
Petrie MC, Verma S, Docherty KF, et al.
JAMA. Pub. online 27 March 2020
Leggi
Meta-analysis of usefulness of treatment of hypercholesterolemia with statins for primary prevention in patients older than 75 years
Kostis JB, Giakoumis M, Zinonos S, et al.
Am J Cardiol. 2020;125(8):1154-7
Leggi
Glycaemic status during pregnancy and longitudinal measures of fetal growth in a multi-racial US population: a prospective cohort study
Li M, Hinkle SN, Grantz KL, et al.
Lancet Diabetes Endocrinol. 2020;8(4):292-300
Leggi
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic S, Aldington SJ, Silva P, et al
Lancet Diabetes Endocrinol. 2020;8(4):337-47
Leggi
Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression
van Sloten TT, Sedaghat S, Carnethon MR, et al.
Lancet Diabetes Endocrinol. 2020;8(4):325-36
Leggi
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Pernicova I, Kelly S, Ajodha S, et al
Lancet Diabetes Endocrinol. 2020;8(4):278-91
Leggi